On Thursday, in the course of current trade, Shares of Altria Group Inc (NYSE:MO), climbed 0.47%, and is now trading at $53.47.
Altria Group, will host a webcast of its business presentation at the Barclays Global Consumer Staples Conference in Boston, Massachusetts on Wednesday, September 9, 2015 at about 9:45 a.m. Eastern Time. The webcast will feature a presentation by Billy Gifford, Altria’s Chief Financial Officer.
Altria Group, Inc., through its auxiliaries, manufactures and sells cigarettes, smokeless products, and wine in the United States and internationally. It offers cigarettes primarily under the Marlboro brand; cigars principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, Husky, and Marlboro Snus brand names.
During an Afternoon trade, Shares of 6D Global Technologies Inc (NASDAQ:SIXD), dipped -1.38%, and is now trading at $2.85.
6D Global Technologies, declared that the Company will open an office in Ireland, marking the official launch of the company’s European operations.
To service customers outside the United States, 6D Global has begun expansion of its operations into the European market with the formation of an Irish office, a key milestone for 6D Global who already works with businesses and agencies in different industry sectors around the world. The key functions of the Dublin-based 6D Global will be sales and solution support of the company’s growing European business, in addition to extending support access for all of 6D Global’s clients looking to expand globally.
6D Global was introduced to Ireland through ConnectIreland, the company responsible for delivering the Government’s Succeed in Ireland initiative, as part of the Action Plan for Jobs, in association with IDA Ireland. Many of the world’s biggest and most successful companies across a range of industry sectors already have considerable operations in Ireland.
6D Global Technologies, Inc. provides digital business solutions serving the digital marketing and technology needs of top tier organizations worldwide. The company’s service portfolio comprises mobile application development, digital and content administration, big data analysis, enterprise resource planning, and information technology (IT) infrastructure staffing.
Finally, Depomed Inc (NASDAQ:DEPO), gained 0.57% Thursday.
Depomed, commented on Horizon Pharma plc’s (HZNP) (“Horizon”) declarement that it intends to request that Depomed’s Board of Directors (“Depomed Board”) set a record date to determine the shareholders eligible to request a special meeting.
The Depomed Board will review the request when it is received. Offered that such request is received recently and contains the information required under Depomed’s bylaws, the Depomed Board will, no later than August 31, 2015, fix a record date to determine shareholders entitled to request a special meeting, as contemplated by the bylaws. Under the bylaws, the record date to determine shareholders entitled to call a special meeting shall be not more than 60 days after the date on which the Depomed Board takes action to fix the record date. The bylaws provide that any request to call a special meeting must, among other things, be signed by the holders of shares entitled to cast not less than 10% of the votes at such meeting and must be received by Depomed within 30 days after the specified record date.
Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States. It offers Gralise (gabapentin), an once-daily product for the administration of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks in adults; Zipsor (diclofenac potassium) liquid filled capsule, a non-steroidal anti-inflammatory drug for the treatment of mild to moderate acute pain in adults; and Lazanda (fentanyl) nasal spray, an intranasal fentanyl drug used to manage breakthrough pain in adults.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
